Treatment Efficacy for Drug Abuse and AIDS Prevention - 2
Phase 2
Completed
- Conditions
- Heroin DependenceCocaine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000211
- Locations
- ๐บ๐ธ
McLean Hospital, Dept. of Psychiatry, Belmont, Massachusetts, United States
Infusion Laboratory: Protocol 5 (Flupenthixol) - 14
Phase 1
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-11
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000349
- Locations
- ๐บ๐ธ
Friends Research Institute, Los Angeles, California, United States
Cognitive Correlates of Substance Abuse - 11
Phase 4
- Conditions
- Amphetamine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-11
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 80
- Registration Number
- NCT00000346
- Locations
- ๐บ๐ธ
Friends Research Institute, Los Angeles, California, United States
Activity Monitoring Assessment of Opiate Withdrawal - 4
Phase 2
Completed
- Conditions
- Opioid-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-31
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000335
- Locations
- ๐บ๐ธ
Washington DC VA, Washington, District of Columbia, United States
Predictive Values of Serotonergic Alterations for Outcome - 2
Phase 1
Terminated
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000313
- Locations
- ๐บ๐ธ
VA Medical Center, Brooklyn, New York, United States
Trial of Buprenorphine/Naloxone for Opiate Dependence - 2
Phase 2
Completed
- Conditions
- Opioid-Related DisordersSubstance-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-18
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000353
- Locations
- ๐บ๐ธ
University of Pennsylvania, Philadelphia, Pennsylvania, United States
Temporal Discounting Delayed Outcomes on Opioid-Dependent Outpatients - 20
Phase 2
Completed
- Conditions
- Opioid-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2008-11-20
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000238
- Locations
- ๐บ๐ธ
Treatment Research Center, Burlington, Vermont, United States
Flupenthixol Treatment in Schizophrenic Cocaine Abusers - 1
Phase 2
Completed
- Conditions
- Cocaine-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000266
- Locations
- ๐บ๐ธ
New York State Psychiatric Institute, New York, New York, United States
Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1
Phase 2
Completed
- Conditions
- Substance-Related DisordersOpioid-Related Disorders
- Interventions
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 202
- Registration Number
- NCT00000318
- Locations
- ๐บ๐ธ
APT Residential Services Division, New Haven, Connecticut, United States
Brain Changes in Stimulant Dependent Subjects - 8
Phase 4
Completed
- Conditions
- Substance-Related Disorders
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 90
- Registration Number
- NCT00000343
- Locations
- ๐บ๐ธ
Friends Research Institute, Los Angeles, California, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath